US Stock MarketDetailed Quotes

EVAX Evaxion Biotech

Watchlist
  • 0.920
  • +0.030+3.36%
Close Dec 20 16:00 ET
  • 0.897
  • -0.023-2.53%
Post 20:01 ET
5.40MMarket Cap-0.33P/E (TTM)

Evaxion Biotech Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(FY)Dec 31, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
(FY)Dec 31, 2021
(Q4)Dec 31, 2021
(Q3)Sep 30, 2021
(Q2)Jun 30, 2021
(Q1)Mar 31, 2021
(FY)Dec 31, 2020
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
31.36%-17.69M
-17.51%-25.77M
30.69%-5.19M
-102.87%-8.19M
-76.34%-21.93M
-4.12M
-127.67%-6.3M
-225.14%-7.49M
-36.78%-4.04M
-77.20%-12.44M
Net income from continuing operations
4.51%-22.13M
5.56%-23.17M
30.08%-4.77M
-41.49%-5.79M
-63.35%-24.53M
---8.37M
-30.92%-5.25M
-87.34%-6.82M
-32.07%-4.09M
-34.15%-15.02M
Operating gains losses
28.61%-282K
---395K
----
----
----
----
----
----
----
----
Depreciation and amortization
7.71%615K
65.99%571K
----
----
227.62%344K
----
----
----
----
29.63%105K
Deferred tax
1.40%-984K
-425.26%-998K
----
----
90.81%-190K
----
----
----
----
-150.55%-2.07M
Other non cash items
356.23%1.36M
46.57%-530K
-1,271.43%-820K
86.81%-129K
-824.09%-992K
--54K
-112.79%-138K
-69.30%70K
-292.90%-978K
-4.86%137K
Change In working capital
154.29%1.56M
-332.58%-2.88M
157.86%427K
-308.96%-2.17M
475.35%1.24M
--1.84M
-645.78%-906K
-348.48%-738K
389.94%1.04M
-62.48%215K
-Change in receivables
174.50%1.11M
-179.76%-1.49M
----
----
174.49%1.86M
----
----
----
----
-642.14%-2.5M
-Change in payables and accrued expense
132.71%455K
-122.20%-1.39M
----
----
-123.05%-626K
----
----
----
----
198.46%2.72M
Cash from discontinued investing activities
Operating cash flow
31.36%-17.69M
-17.51%-25.77M
30.69%-5.19M
-102.87%-8.19M
-76.34%-21.93M
---4.12M
-127.67%-6.3M
-225.14%-7.49M
-36.78%-4.04M
-77.20%-12.44M
Investing cash flow
Cash flow from continuing investing activities
65.30%-93K
79.85%-268K
84.44%-77K
51.38%-159K
-238.42%-1.33M
-177K
-6,520.00%-331K
-1,000.00%-495K
-303.70%-327K
-477.94%-393K
Net PPE purchase and sale
70.21%-87K
77.54%-292K
83.73%-83K
35.82%-181K
-263.13%-1.3M
---176K
-16,500.00%-332K
-5,000.00%-510K
-340.63%-282K
-426.47%-358K
Net intangibles purchase and sale
--0
--0
----
--0
-71.43%-60K
--0
--0
--0
---60K
---35K
Net investment purchase and sale
-125.00%-6K
-20.00%24K
-60.00%6K
46.67%22K
--30K
---1K
133.33%1K
--15K
188.24%15K
----
Cash from discontinued investing activities
Investing cash flow
65.30%-93K
79.85%-268K
84.44%-77K
51.38%-159K
-238.42%-1.33M
---177K
-6,520.00%-331K
-1,000.00%-495K
-303.70%-327K
-477.94%-393K
Financing cash flow
Cash flow from continuing financing activities
36.14%10.69M
-84.23%7.85M
-757.14%-300K
-69.36%7.74M
464.87%49.81M
24.65M
-101.00%-65K
-94.44%-35K
140,388.89%25.25M
-7.27%8.82M
Net issuance payments of debt
-108.51%-632K
2,669.20%7.43M
-205.71%-107K
18,095.35%7.74M
-290.54%-289K
---144K
-252.63%-67K
-94.44%-35K
-138.89%-43K
-193.67%-74K
Net common stock issuance
2,042.06%9.17M
-99.21%428K
--28K
--0
497.12%53.85M
--25.95M
-99.98%1K
--0
--27.9M
-4.48%9.02M
Proceeds from stock option exercised by employees
--2.59M
--0
----
----
--0
----
----
----
----
----
Net other financing activities
---432K
----
----
----
-2,837.50%-3.76M
---1.16M
--1K
--0
---2.61M
-884.62%-128K
Cash from discontinued financing activities
Financing cash flow
36.14%10.69M
-84.23%7.85M
-757.14%-300K
-69.36%7.74M
464.87%49.81M
--24.65M
-101.00%-65K
-94.44%-35K
140,388.89%25.25M
-7.27%8.82M
Net cash flow
Beginning cash position
-59.01%13.18M
451.35%32.17M
16.52%31.41M
451.35%32.17M
-38.97%5.83M
--11.94M
360.20%18.8M
324.82%26.96M
-38.97%5.83M
28.60%9.56M
Current changes in cash
61.00%-7.09M
-168.53%-18.19M
30.57%-5.57M
-102.91%-607K
761.40%26.54M
--20.36M
-280.40%-6.69M
-238.88%-8.02M
785.14%20.89M
-265.76%-4.01M
Effect of exchange rate changes
35.94%-508K
-277.62%-793K
-327.54%-590K
-164.94%-150K
-172.92%-210K
---139K
-302.47%-164K
-230.19%-138K
240.00%231K
197.63%288K
End cash Position
-57.65%5.58M
-59.01%13.18M
34.33%25.25M
16.52%31.41M
451.35%32.17M
--32.17M
51.67%11.94M
360.20%18.8M
324.82%26.96M
-38.97%5.83M
Free cash flow
31.80%-17.78M
-11.90%-26.07M
34.07%-5.27M
-91.16%-8.37M
-81.54%-23.29M
---4.29M
-139.50%-6.63M
-240.63%-8M
-45.22%-4.38M
-81.05%-12.83M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
Unqualified Opinion with Explanatory Notes
--
--
Unqualified Opinion
--
--
--
--
--
(FY)Dec 31, 2023(FY)Dec 31, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022(FY)Dec 31, 2021(Q4)Dec 31, 2021(Q3)Sep 30, 2021(Q2)Jun 30, 2021(Q1)Mar 31, 2021(FY)Dec 31, 2020
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 31.36%-17.69M-17.51%-25.77M30.69%-5.19M-102.87%-8.19M-76.34%-21.93M-4.12M-127.67%-6.3M-225.14%-7.49M-36.78%-4.04M-77.20%-12.44M
Net income from continuing operations 4.51%-22.13M5.56%-23.17M30.08%-4.77M-41.49%-5.79M-63.35%-24.53M---8.37M-30.92%-5.25M-87.34%-6.82M-32.07%-4.09M-34.15%-15.02M
Operating gains losses 28.61%-282K---395K--------------------------------
Depreciation and amortization 7.71%615K65.99%571K--------227.62%344K----------------29.63%105K
Deferred tax 1.40%-984K-425.26%-998K--------90.81%-190K-----------------150.55%-2.07M
Other non cash items 356.23%1.36M46.57%-530K-1,271.43%-820K86.81%-129K-824.09%-992K--54K-112.79%-138K-69.30%70K-292.90%-978K-4.86%137K
Change In working capital 154.29%1.56M-332.58%-2.88M157.86%427K-308.96%-2.17M475.35%1.24M--1.84M-645.78%-906K-348.48%-738K389.94%1.04M-62.48%215K
-Change in receivables 174.50%1.11M-179.76%-1.49M--------174.49%1.86M-----------------642.14%-2.5M
-Change in payables and accrued expense 132.71%455K-122.20%-1.39M---------123.05%-626K----------------198.46%2.72M
Cash from discontinued investing activities
Operating cash flow 31.36%-17.69M-17.51%-25.77M30.69%-5.19M-102.87%-8.19M-76.34%-21.93M---4.12M-127.67%-6.3M-225.14%-7.49M-36.78%-4.04M-77.20%-12.44M
Investing cash flow
Cash flow from continuing investing activities 65.30%-93K79.85%-268K84.44%-77K51.38%-159K-238.42%-1.33M-177K-6,520.00%-331K-1,000.00%-495K-303.70%-327K-477.94%-393K
Net PPE purchase and sale 70.21%-87K77.54%-292K83.73%-83K35.82%-181K-263.13%-1.3M---176K-16,500.00%-332K-5,000.00%-510K-340.63%-282K-426.47%-358K
Net intangibles purchase and sale --0--0------0-71.43%-60K--0--0--0---60K---35K
Net investment purchase and sale -125.00%-6K-20.00%24K-60.00%6K46.67%22K--30K---1K133.33%1K--15K188.24%15K----
Cash from discontinued investing activities
Investing cash flow 65.30%-93K79.85%-268K84.44%-77K51.38%-159K-238.42%-1.33M---177K-6,520.00%-331K-1,000.00%-495K-303.70%-327K-477.94%-393K
Financing cash flow
Cash flow from continuing financing activities 36.14%10.69M-84.23%7.85M-757.14%-300K-69.36%7.74M464.87%49.81M24.65M-101.00%-65K-94.44%-35K140,388.89%25.25M-7.27%8.82M
Net issuance payments of debt -108.51%-632K2,669.20%7.43M-205.71%-107K18,095.35%7.74M-290.54%-289K---144K-252.63%-67K-94.44%-35K-138.89%-43K-193.67%-74K
Net common stock issuance 2,042.06%9.17M-99.21%428K--28K--0497.12%53.85M--25.95M-99.98%1K--0--27.9M-4.48%9.02M
Proceeds from stock option exercised by employees --2.59M--0----------0--------------------
Net other financing activities ---432K-------------2,837.50%-3.76M---1.16M--1K--0---2.61M-884.62%-128K
Cash from discontinued financing activities
Financing cash flow 36.14%10.69M-84.23%7.85M-757.14%-300K-69.36%7.74M464.87%49.81M--24.65M-101.00%-65K-94.44%-35K140,388.89%25.25M-7.27%8.82M
Net cash flow
Beginning cash position -59.01%13.18M451.35%32.17M16.52%31.41M451.35%32.17M-38.97%5.83M--11.94M360.20%18.8M324.82%26.96M-38.97%5.83M28.60%9.56M
Current changes in cash 61.00%-7.09M-168.53%-18.19M30.57%-5.57M-102.91%-607K761.40%26.54M--20.36M-280.40%-6.69M-238.88%-8.02M785.14%20.89M-265.76%-4.01M
Effect of exchange rate changes 35.94%-508K-277.62%-793K-327.54%-590K-164.94%-150K-172.92%-210K---139K-302.47%-164K-230.19%-138K240.00%231K197.63%288K
End cash Position -57.65%5.58M-59.01%13.18M34.33%25.25M16.52%31.41M451.35%32.17M--32.17M51.67%11.94M360.20%18.8M324.82%26.96M-38.97%5.83M
Free cash flow 31.80%-17.78M-11.90%-26.07M34.07%-5.27M-91.16%-8.37M-81.54%-23.29M---4.29M-139.50%-6.63M-240.63%-8M-45.22%-4.38M-81.05%-12.83M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory NotesUnqualified Opinion with Explanatory Notes----Unqualified Opinion----------
Trending US Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
NVIDIA
NVDA
+3.08%
Adobe
ADBE
+2.24%
Salesforce
CRM
+2.21%
Apple
AAPL
+1.88%
Alphabet-C
GOOG
+1.72%

Unlock the Full List